Trump Announces Deals to Cut Weight-Loss Drug Prices and Expand Medicare Coverage
TL;DR Summary
Former President Donald Trump announced agreements with Eli Lilly and Novo Nordisk to lower the prices of weight-loss drugs like Wegovy and Zepbound, making them more accessible through Medicare, Medicaid, and a new government website, TrumpRx, with prices ranging from $149 to $350 per month, depending on the drug and coverage.
- Trump unveils deals to lower US weight-loss drug prices BBC
- Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNN
- Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month The New York Times
- President Trump on Lowering Price of Weight Loss Drugs C-SPAN
- Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBC
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
90%
531 → 51 words
Want the full story? Read the original article
Read on BBC